Ascendis’ (ASND) TransCon hGH Gets EU Nod for Pediatric GHD Posted byZacks Equity Research January 14, 2022 Leave a comment on Ascendis’ (ASND) TransCon hGH Gets EU Nod for Pediatric GHD Ascendis Pharma (ASND) gets nod in Europe for TransCon hGH for the treatment of pediatric growth hormone deficiency.